SuspendedPhase 2NCT05223036
Testing Obeticholic Acid for Familial Adenomatous Polyposis
Studying Attenuated familial adenomatous polyposis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Eduardo Vilar-SanchezM.D. Anderson Cancer Center
- Intervention
- Biopsy Procedure(procedure)
- Enrollment
- 80 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2029
Study locations (7)
- Mayo Clinic in Arizona, Scottsdale, Arizona, United States
- University of Kansas Cancer Center, Kansas City, Kansas, United States
- Dana-Farber Cancer Institute, Boston, Massachusetts, United States
- University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States
- Cleveland Clinic Foundation, Cleveland, Ohio, United States
- M D Anderson Cancer Center, Houston, Texas, United States
- University of Puerto Rico, San Juan, Puerto Rico
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05223036 on ClinicalTrials.gov